- Home
- SAFE vs ARDX Comparison
SAFE vs ARDX Comparison
Compare SAFE & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAFE
- ARDX
- Stock Information
- Founded
- SAFE 2016
- ARDX 2007
- Country
- SAFE United States
- ARDX United States
- Employees
- SAFE N/A
- ARDX N/A
- Industry
- SAFE Real Estate Investment Trusts
- ARDX Biotechnology: Pharmaceutical Preparations
- Sector
- SAFE Real Estate
- ARDX Health Care
- Exchange
- SAFE Nasdaq
- ARDX Nasdaq
- Market Cap
- SAFE 1.1B
- ARDX 882.9M
- IPO Year
- SAFE 2017
- ARDX 2014
- Fundamental
- Price
- SAFE $15.43
- ARDX $4.49
- Analyst Decision
- SAFE Buy
- ARDX Strong Buy
- Analyst Count
- SAFE 9
- ARDX 9
- Target Price
- SAFE $22.33
- ARDX $10.17
- AVG Volume (30 Days)
- SAFE 397.2K
- ARDX 4.5M
- Earning Date
- SAFE 07-28-2025
- ARDX 07-31-2025
- Dividend Yield
- SAFE 4.58%
- ARDX N/A
- EPS Growth
- SAFE N/A
- ARDX N/A
- EPS
- SAFE 1.46
- ARDX N/A
- Revenue
- SAFE $391,206,000.00
- ARDX $361,706,000.00
- Revenue This Year
- SAFE $0.35
- ARDX $11.39
- Revenue Next Year
- SAFE $4.85
- ARDX $32.84
- P/E Ratio
- SAFE $10.59
- ARDX N/A
- Revenue Growth
- SAFE 2.64
- ARDX 127.33
- 52 Week Low
- SAFE $13.68
- ARDX $3.21
- 52 Week High
- SAFE $28.80
- ARDX $7.18
- Technical
- Relative Strength Index (RSI)
- SAFE 48.30
- ARDX 64.55
- Support Level
- SAFE $15.08
- ARDX $4.14
- Resistance Level
- SAFE $15.98
- ARDX $4.71
- Average True Range (ATR)
- SAFE 0.50
- ARDX 0.19
- MACD
- SAFE -0.02
- ARDX 0.11
- Stochastic Oscillator
- SAFE 35.53
- ARDX 81.97
About SAFE Safehold Inc. New
Safehold Inc is a REIT that operates its business by acquiring, managing, and capitalizing ground leases. Ground leases are long-term contracts between the landlord (the Company) and a tenant or leaseholder. Ground leases generally represent ownership of the land underlying commercial real estate projects that are net leased by the fee owner of the land to the owners/operators of the real estate projects built thereon.
About ARDX Ardelyx Inc.
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.